Why Low-Dose-Rate Brachytherapy Deserves a Second Look
Dr. E. David Crawford, Dr. Jason M. Hafron, and Dr. Michael Granieri discuss why low-dose-rate brachytherapy remains an important treatment option for localized prostate cancer, highlighting patient selection, multidisciplinary collaboration, and successful implementation within modern urology practices.
Read More